CRBP CIK: 1595097

Corbus Pharmaceuticals Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.2
FY22:
−37.5
FY23:
−36.1
FY24:
−41.8
FY25:
−64.5
Change from FY21 to FY25
millions USD
FY21:
−73.4
FY22:
30.1
FY23:
35.6
FY24:
−121
FY25:
−1.64
Change from FY21 to FY25
millions USD
FY21:
60.8
FY22:
−0.53
FY23:
−2.82
FY24:
167
FY25:
77.4
millions USD
FY21:
−60.8
FY22:
−8.00
FY23:
−3.28
FY24:
3.47
FY25:
11.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.2
FY22:
−37.6
FY23:
−36.1
FY24:
−41.8
FY25:
−64.5

All amounts in millions USD Data source:SEC EDGAR